SLN
Price
$23.00
Change
+$0.06 (+0.26%)
Updated
May 17, 6:59 PM EST
SST
Price
$1.54
Change
-$0.03 (-1.91%)
Updated
May 17, 6:59 PM EST
81 days until earnings call
Ad is loading...

SLN vs SST

Header iconSLN vs SST Comparison
Open Charts SLN vs SSTBanner chart's image
Silence Therapeutics
Price$23.00
Change+$0.06 (+0.26%)
Volume$60.15K
CapitalizationN/A
System1
Price$1.54
Change-$0.03 (-1.91%)
Volume$55.46K
CapitalizationN/A
View a ticker or compare two or three
SLN vs SST Comparison Chart

Loading...

SLNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
SLN vs. SST commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLN is a Hold and SST is a Hold.

COMPARISON
Comparison
May 19, 2024
Stock price -- (SLN: $23.00 vs. SST: $1.55)
Brand notoriety: SLN and SST are both not notable
SLN represents the Biotechnology, while SST is part of the Miscellaneous Commercial Services industry
Current volume relative to the 65-day Moving Average: SLN: 74% vs. SST: 18%
Market capitalization -- SLN: $979.86M vs. SST: $134.1M
SLN [@Biotechnology] is valued at $979.86M. SST’s [@Miscellaneous Commercial Services] market capitalization is $134.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The market cap for tickers in the [@Miscellaneous Commercial Services] industry ranges from $80.94B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B. The average market capitalization across the [@Miscellaneous Commercial Services] industry is $4.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SST’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 0 green FA rating(s).

  • SST’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 0 green, 5 red.
According to our system of comparison, both SST and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLN’s TA Score shows that 6 TA indicator(s) are bullish while SST’s TA Score has 4 bullish TA indicator(s).

  • SLN’s TA Score: 6 bullish, 2 bearish.
  • SST’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SLN is a better buy in the short-term than SST.

Price Growth

SLN (@Biotechnology) experienced а +8.44% price change this week, while SST (@Miscellaneous Commercial Services) price change was -3.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

The average weekly price growth across all stocks in the @Miscellaneous Commercial Services industry was +1.70%. For the same industry, the average monthly price growth was +7.86%, and the average quarterly price growth was +20.58%.

Reported Earning Dates

SLN is expected to report earnings on May 14, 2024.

SST is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Miscellaneous Commercial Services (+1.70% weekly)

The sector produces general business services, and are not classified elsewhere. For example, FleetCor Technologies provides fuel cards and workforce payment products and services; Copart, Inc. provides online vehicle auction and remarketing services across various nations; Equifax Inc. collects and aggregates credit information on consumers and businesses worldwide, along with selling credit monitoring and fraud-prevention services. Many of the companies in this category have multi-billion market capitalizations.

SUMMARIES
A.I.dvisor published
a Summary for SLN with price predictions.
OPEN
A.I.dvisor published
a Summary for SST with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SLN($980M) has a higher market cap than SST($134M). SLN YTD gains are higher at: 32.412 vs. SST (-30.180).
SLNSSTSLN / SST
Capitalization980M134M731%
EBITDAN/A22.3M-
Gain YTD32.412-30.180-107%
P/E RatioN/A41.32-
RevenueN/A402M-
Total CashN/A135M-
Total DebtN/A355M-
FUNDAMENTALS RATINGS
SST: Fundamental Ratings
SST
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLNSST
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
44%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
54%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 12 days ago
59%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
53%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
66%
View a ticker or compare two or three
Ad is loading...
SLNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLORX8.820.07
+0.80%
Cohen & Steers Future of Energy R
SFPAX9.550.05
+0.53%
Saratoga Financial Service A
LMCSX35.100.09
+0.26%
Lord Abbett Mid Cap Stock R4
OLVCX19.610.03
+0.15%
JPMorgan Large Cap Value C
WOOQX17.340.01
+0.06%
JPMorgan SMID Cap Equity R4

SLN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+0.26%
CLLS - SLN
34%
Loosely correlated
-1.64%
TGTX - SLN
25%
Poorly correlated
-5.40%
VKTX - SLN
24%
Poorly correlated
-2.98%
RNAC - SLN
23%
Poorly correlated
+0.34%
OCGN - SLN
22%
Poorly correlated
-3.54%
More

SST and Stocks

Correlation & Price change

A.I.dvisor tells us that SST and ABM have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SST and ABM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SST
1D Price
Change %
SST100%
-1.27%
ABM - SST
25%
Poorly correlated
+0.94%
CBZ - SST
23%
Poorly correlated
+0.80%
RBA - SST
23%
Poorly correlated
-0.12%
EFX - SST
22%
Poorly correlated
-0.48%
NSSC - SST
22%
Poorly correlated
+1.54%
More